EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 3.0

Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database

Mariko Kozaru, Hiroko Kambara, Akari Higuchi, Tatsuki Kagatsume, Keiko Hosohata iD

Vascular Health and Risk Management · 2024

DOI: 10.2147/vhrm.s482190 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Vascular Health and Risk Management, 2024. Verfasst von Mariko Kozaru und 4 weiteren Autor:innen. Beteiligte Einrichtung: Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, Ja…. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Clopidogrel, Lung Diseases, Interstitial, Pharmacovigilance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The P2Y12 receptor inhibitors clopidogrel and prasugrel are widely used. Clopidogrel and prasugrel have different metabolic pathways, but whether their adverse event (AE) profiles differ significantly is unclear.

Objective

This study aimed to compare the possible AEs induced by clopidogrel and prasugrel and to assess the rank-order of their AEs submitted to a spontaneous reporting database. Materials and Methods: Data were extracted from the Japanese Adverse Drug Event Report database (JADER). Reports of AEs associated with clopidogrel and prasugrel were analyzed to calculate the reporting odds ratios (RORs) and 95% confidence intervals (CIs).

Results

Based on 5869 reports for clopidogrel (69.6%, men) and 513 reports for prasugrel (74.1%, men), 703 and 135 different AEs were identified, respectively. Bleeding complications including hemorrhage were commonly reported for both clopidogrel and prasugrel. As for AEs related to clopidogrel, unexpected AEs such as interstitial lung disease (227 reports; ROR, 1.77; 95% CI, 1.49-2.10), abnormal hepatic function (137 reports; ROR, 1.27; 95% CI, 1.07-1.51), and hepatocellular injury (96 reports; ROR, 120.0; 95% CI, 94.9-151.8) ranked at relatively high positions based on the number of occurrences, unlike prasugrel.

Conclusion

This analysis of the national pharmacovigilance database highlights distinct AE profiles for clopidogrel and prasugrel. Unexpected AEs associated with clopidogrel were identified, providing valuable insights for clinical monitoring and patient safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsClopidogrelLung Diseases, InterstitialPharmacovigilancePlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsAdultAgedFemaleHumansMaleMiddle AgedDatabases, FactualHemorrhageJapanRisk AssessmentRisk Factors

Stichwörter der Autor:innen

P2Y12 platelet inhibitoradverse eventspharmacovigilancereporting odds ratiosignal detectionspontaneous reporting system

Substanzen

ClopidogrelPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor Antagonists

Autor:innen und Institutionen

  • Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, Japan.

ORCID-Profile: Keiko Hosohata

Zitieren

APA

Kozaru, M., Kambara, H., Higuchi, A., Kagatsume, T., & Hosohata, K. (2024). Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.s482190

Vancouver

Kozaru M, Kambara H, Higuchi A, Kagatsume T, Hosohata K. Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database. Vascular Health and Risk Management. 2024. doi:10.2147/vhrm.s482190

BibTeX
@article{Kozaru2024,
  author = {Kozaru, Mariko and Kambara, Hiroko and Higuchi, Akari and Kagatsume, Tatsuki and Hosohata, Keiko},
  title = {Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database},
  journal = {Vascular Health and Risk Management},
  year = {2024},
  doi = {10.2147/vhrm.s482190}
}
Kostenlos starten →